Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Liabilities and Shareholders Equity (2018 - 2025)

Historic Liabilities and Shareholders Equity for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $202.4 million.

  • Viemed Healthcare's Liabilities and Shareholders Equity rose 1936.81% to $202.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $742.1 million, marking a year-over-year increase of 1537.02%. This contributed to the annual value of $177.1 million for FY2024, which is 1431.55% up from last year.
  • According to the latest figures from Q3 2025, Viemed Healthcare's Liabilities and Shareholders Equity is $202.4 million, which was up 1936.81% from $184.6 million recorded in Q2 2025.
  • In the past 5 years, Viemed Healthcare's Liabilities and Shareholders Equity ranged from a high of $202.4 million in Q3 2025 and a low of $111.0 million during Q2 2021
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $149.1 million (2023), whereas its average is $144.1 million.
  • In the last 5 years, Viemed Healthcare's Liabilities and Shareholders Equity crashed by 103.76% in 2021 and then surged by 3234.03% in 2023.
  • Quarter analysis of 5 years shows Viemed Healthcare's Liabilities and Shareholders Equity stood at $118.0 million in 2021, then decreased by 0.78% to $117.0 million in 2022, then soared by 32.34% to $154.9 million in 2023, then increased by 14.32% to $177.1 million in 2024, then rose by 14.28% to $202.4 million in 2025.
  • Its last three reported values are $202.4 million in Q3 2025, $184.6 million for Q2 2025, and $178.1 million during Q1 2025.